It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Sulfasalazine and plaquenil Info plaquenil Plaquenil hydroxycholoroquine is a medication used to treat lupus, rheumatoid arthritis and other inflammatory and dermatologic conditions. It is very effective and the risk of damage to the eye is very low the first five years if the patient is receiving the recommended dose and does not have special risk factors like kidney damage. This may lead to lasting eyesight problems. The risk may be higher if you have some types of eye or kidney problems. The risk may also be higher with some doses of hydroxychloroquine, if you use hydroxychloroquine for longer than 5 years, or if you take certain other drugs like tamoxifen. Call your doctor right away if you have any eyesight changes like blurred or foggy eyesight, trouble focusing or reading, or trouble seeing in dim light. The specialities which for good reason initiate a prescription of hydroxychloroquine need to support their colleagues in ophthalmology who are then tasked with monitoring for complications. Today, it is used to treat rheumatoid arthritis, some symptoms of lupus, childhood arthritis (or juvenile idiopathic arthritis) and other autoimmune diseases. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Hydroxychloroquine monitoring ophthalmology Hydroxychloroquine DermNet NZ, Hydroxychloroquine Indications, Side Effects, Warnings. Chloroquine resistance mechanismPlaquenil price increase 2017Plaquenil sjsChloroquine toxicity eyeTests to get before starting hydroxychloroquine Hydroxychloroquine is a quinoline medicine used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria. Hydroxychloroquine Uses, Dosage & Side Effects -. Monitoring for hydroxychloroquine retinopathy Eye. AMERICAN COLLEGE OF RHEUMATOLOGY. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. DMARD MONITORING GUIDELINES – FOR GP INFORMATION Hydroxychloroquine A. Indications Licensed RA, connective tissue diseases systemic and discoid lupus and some photosensitive dermatological conditions B. Dose Grade of evidence C Typical regime 200–400 mg daily. Dosage may be reduced to 200 mg daily depending on clinical response. Multifocal Electroretinopathy measures electrical responses of various cell types in the retina. It is thought that although the bull’s eye seen on ophthalmic exam represents a disruption of the pigmented part of the retina, it is the photoreceptors that are the targets of hydroxychloroquine toxicity.